Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.360 and welcome to Gilead's second quarter, 2025 earnings conference call. 00:00:04.360 -- 00:00:07.120 My name is Rebecca and I'll be today's host. 00:00:07.120 -- 00:00:11.960 In a moment, we'll begin our prepared remarks followed by our Q&A session. 00:00:11.960 -- 00:00:17.380 To ask a question, please press star one. To withdraw your question, press star two. 00:00:17.380 -- 00:00:22.000 Now I'll hand the call over to Jackie Ross, Senior Vice President of Treasury and Investor 00:00:22.000 -- 00:00:24.000 Relations. 00:00:24.040 -- 00:00:28.540 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:28.540 -- 00:00:31.620 results for the second quarter of 2025. 00:00:31.620 -- 00:00:35.760 The press release, slides and supplementary data are available on the investor section 00:00:35.760 -- 00:00:38.780 of our website at gilead.com. 00:00:38.780 -- 00:00:42.820 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:42.820 -- 00:00:47.900 O'Day, our Chief Commercial Officer, Joanna Mercier, our Chief Medical Officer, 00:00:47.900 -- 00:00:52.100 Dietmar Berger, and our Chief Financial Officer, Andrew Dickinson. 00:00:52.100 -- 00:00:56.380 After that, we'll open the call to Q&A where the team will be joined by Cindy Peretti, 00:00:56.380 -- 00:01:01.420 the Executive Vice President of KITE. Let me remind you that we will be making 00:01:01.420 -- 00:01:06.480 forward-looking statements. Please refer to slide two regarding the risks and uncertainties 00:01:06.480 -- 00:01:11.960 relating to forward-looking statements that could cause actual results to differ materially. 00:01:11.960 -- 00:01:15.220 With that, I'll turn the call over to Dan. 00:01:15.220 -...